Unbound MEDLINE

Dose-related effect of statins on atrial fibrillation after cardiac surgery. The Annals of thoracic surgery [Ann Thorac Surg] Journal article

 
TitleDose-related effect of statins on atrial fibrillation after cardiac surgery.
Author(s)Kourliouros A, De Souza A, Roberts N, Marciniak A, Tsiouris A, Valencia O, Camm J, Jahangiri M 
InstitutionDepartment of Cardiothoracic Surgery, St. George's Hospital, London, United Kingdom.
SourceAnn Thorac Surg 2008 May; 85(5):1515-20.
MeSHAged
Aged, 80 and over
Aortic Valve
Atrial Fibrillation
Cohort Studies
Coronary Artery Bypass
Cross-Sectional Studies
Dose-Response Relationship, Drug
Female
Heart Valve Prosthesis Implantation
Heptanoic Acids
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Male
Middle Aged
Postoperative Complications
Pyrroles
Retrospective Studies
Risk Factors
Simvastatin
Treatment Outcome
AbstractBACKGROUND: Atrial fibrillation (AF) is the most common heart rhythm abnormality after cardiac surgery. It increases morbidity and prolongs hospital stay. A role for statins in the prevention of AF has been suggested. We hypothesized that the incidence of postoperative AF due to statin therapy is dose-related.
METHODS: A retrospective study of 680 consecutive patients undergoing coronary bypass graft surgery and/or aortic valve replacement was done. Excluded were 57 patients (8.4%) with history of AF, permanent pacemakers, and those receiving antiarrhythmic medication. Preoperative statin treatment and occurrence of postoperative AF were examined using propensity score matching to adjust for differences in patient characteristics between the statin and no-statin groups.
RESULTS: The cohort comprised 623 patients. The statin group had a 27.1% incidence of postoperative AF vs 38.3% in the no-statin group (adjusted odds ratio [OR], 2.00; 95% confidence interval, 1.24 to 3.24; p = 0.004). Simvastatin (40 mg) and atorvastatin (40 mg) demonstrated the greatest effect on postoperative AF at 15.6% and 21.2%, respectively, vs no statins (respective adjusted ORs, 3.89 [p < 0.0001] and 2.76 [p = 0.012]). Intermediate-dose (20 mg) statins were also effective against AF, at 24.4% for simvastatin (adjusted OR, 2.32; p = 0.004) and 26.4% for atorvastatin (adjusted OR, 1.99, p = 0.047). Low-dose statins, simvastatin or atorvastatin (10 mg), did not influence postoperative AF.
CONCLUSIONS: Statin treatment may reduce the incidence of AF after cardiac surgery. Higher-dose statins have the greatest preventative effect, whereas low-dose statins do not influence postoperative AF.
Languageeng
Pub Type(s)Comparative Study
Journal Article
PubMed ID18442529
  
Advertise on this site.